We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
GINA
BROWN
gina.brown@imperial.ac.uk
GINA
BROWN
giclinicaltrials@imperial.ac.uk
CAROLINE
MARTIN
c.martin1@imperial.ac.uk
Sokol
Shala
sokol.shala@nihr.ac.uk
Malignant neoplasms of digestive organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
We are trying to find out where, why and how patients get recurrent bowel cancer in their pelvis. We also want to find out which treatments can help. In this study we are introducing a new format for reporting MRIs which provides more detailed information about the recurrence which will improve management of your recurrence and therefore outcome. We will also compare this new structured report with the original scans of the original tumour which will help us understand how this recurrence happened. We hope that by understanding how these recurrences occur we can prevent them from occurring in the future.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Imaging;
You can take part if:
You may not be able to take part if:
- Patients for whom an MRI study is contraindicated - Patients with anal cancer (squamous cell carcinoma and nonadenocarcinoma malignancies) - Patients with irresectable metastatic disease or irresectable synchronous second malignancy - Patients with poor performance status to undergo surgery - Patients with poorly controlled diabetes (for 18F FDG PETCT)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
CAROLINE
MARTIN
c.martin1@imperial.ac.uk
GINA
BROWN
giclinicaltrials@imperial.ac.uk
GINA
BROWN
gina.brown@imperial.ac.uk
Sokol
Shala
sokol.shala@nihr.ac.uk
The study is sponsored by Imperial College of Science, Technology and Medicine and funded by PELICAN CANCER FOUNDATION .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 17065
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
